On The Fly: Pre-market Movers

HIGHER: Matinas BioPharma (MTNB), up 5.6% after reporting topline data from Phase 1 study of MAT2501... Weatherford (WFT), up 8.7% after its joint venture with Schlumberger (SLB) was announced... Snap (SNAP), up 3.5% as several research firms initiated coverage, including Morgan Stanley and Citi... Paratek Pharmaceuticals (PRTK), up 15.1% after Allergan (AGN) and Paratek announced that two sarecycline Phase 3 trials met their primary efficacy endpoints. DOWN AFTER EARNINGS: G-III Apparel (GIII), down 12.8%... Cal-Maine Foods (CALM), down 6.4%. ALSO LOWER: Schlumberger is down 1.1% following the announcement of a joint venture with Weatherford... ArQule (ARQL), down 15.7% after the JET-HCC Phase 3 trial did not meet its primary endpoint.